Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CELC |
---|---|---|
09:32 ET | 8029 | 13.64 |
09:33 ET | 5000 | 13.75 |
09:35 ET | 358 | 13.6 |
09:37 ET | 1557 | 12.99 |
09:39 ET | 175 | 13.1999 |
09:42 ET | 674 | 13.055 |
09:44 ET | 300 | 13.18 |
09:48 ET | 603 | 12.85 |
09:50 ET | 800 | 12.925 |
09:51 ET | 792 | 12.915 |
09:53 ET | 6466 | 12.71 |
09:55 ET | 1899 | 12.14 |
09:57 ET | 5110 | 12.2938 |
10:00 ET | 100 | 12.29 |
10:02 ET | 3311 | 12.4 |
10:04 ET | 2642 | 12.33 |
10:06 ET | 4268 | 12.205 |
10:08 ET | 5242 | 11.985 |
10:09 ET | 700 | 12.08 |
10:11 ET | 1300 | 12.24 |
10:13 ET | 1050 | 12.3 |
10:15 ET | 11488 | 12.205 |
10:18 ET | 900 | 12.23 |
10:22 ET | 801 | 12.125 |
10:24 ET | 450 | 12.11 |
10:26 ET | 200 | 12.16 |
10:27 ET | 100 | 12.0975 |
10:29 ET | 100 | 12.085 |
10:31 ET | 12416 | 12.055 |
10:33 ET | 600 | 12.045 |
10:36 ET | 10460 | 12.135 |
10:38 ET | 4597 | 12.0493 |
10:40 ET | 18240 | 11.66 |
10:42 ET | 1825 | 11.67 |
10:44 ET | 1220 | 11.77 |
10:45 ET | 5391 | 11.665 |
10:47 ET | 100 | 11.77 |
10:49 ET | 1200 | 11.73 |
10:51 ET | 200 | 11.71 |
10:54 ET | 2569 | 11.7 |
10:56 ET | 500 | 11.7417 |
10:58 ET | 100 | 11.71 |
11:03 ET | 5679 | 11.7 |
11:05 ET | 1597 | 11.68 |
11:07 ET | 1016 | 11.8064 |
11:09 ET | 6170 | 12.05 |
11:12 ET | 100 | 12.03 |
11:14 ET | 10100 | 11.955 |
11:16 ET | 300 | 12 |
11:18 ET | 500 | 12.01 |
11:20 ET | 529 | 12.03 |
11:23 ET | 3067 | 12.155 |
11:25 ET | 2700 | 12.155 |
11:27 ET | 500 | 12.155 |
11:30 ET | 14042 | 12.18 |
11:32 ET | 1001 | 12.18 |
11:34 ET | 840 | 12.43 |
11:36 ET | 1100 | 12.32 |
11:38 ET | 7575 | 12.16 |
11:41 ET | 100 | 12.125 |
11:43 ET | 4700 | 12.18 |
11:45 ET | 1385 | 12.145 |
11:48 ET | 100 | 12.2 |
11:50 ET | 200 | 12.22 |
11:52 ET | 4200 | 12.27 |
11:54 ET | 15896 | 12.145 |
11:56 ET | 2915 | 12.054 |
11:57 ET | 12276 | 12.02 |
11:59 ET | 1100 | 12.1 |
12:01 ET | 9705 | 12.075 |
12:03 ET | 800 | 12.03 |
12:06 ET | 4387 | 12.025 |
12:08 ET | 100 | 12.04 |
12:10 ET | 5316 | 12.045 |
12:12 ET | 6616 | 12.02 |
12:14 ET | 6466 | 12.09 |
12:15 ET | 1905 | 12.21 |
12:17 ET | 300 | 12.33 |
12:19 ET | 700 | 12.275 |
12:21 ET | 800 | 12.31 |
12:24 ET | 100 | 12.31 |
12:26 ET | 700 | 12.305 |
12:28 ET | 3556 | 12.235 |
12:30 ET | 300 | 12.1 |
12:32 ET | 1000 | 12.12 |
12:33 ET | 1400 | 12.12 |
12:35 ET | 1800 | 12.215 |
12:37 ET | 800 | 12.18 |
12:39 ET | 1800 | 12.25 |
12:42 ET | 7290 | 12.18 |
12:44 ET | 505 | 12.09 |
12:48 ET | 100 | 12.07 |
12:50 ET | 700 | 12.06 |
12:51 ET | 500 | 12.09 |
12:53 ET | 200 | 12.085 |
12:55 ET | 3024 | 12.14 |
12:57 ET | 682 | 12.135 |
01:00 ET | 1625 | 12.11 |
01:02 ET | 3431 | 12.135 |
01:04 ET | 2456 | 12.14 |
01:06 ET | 400 | 12.18 |
01:08 ET | 1705 | 12.31 |
01:09 ET | 21018 | 12.28 |
01:11 ET | 4942 | 12.21 |
01:13 ET | 300 | 12.18 |
01:15 ET | 3348 | 12.325 |
01:18 ET | 1100 | 12.21 |
01:20 ET | 100 | 12.205 |
01:22 ET | 100 | 12.19 |
01:24 ET | 500 | 12.24 |
01:27 ET | 500 | 12.23 |
01:29 ET | 1432 | 12.36 |
01:31 ET | 2005 | 12.36 |
01:33 ET | 600 | 12.375 |
01:36 ET | 9733 | 12.4 |
01:38 ET | 3705 | 12.525 |
01:40 ET | 1200 | 12.39 |
01:42 ET | 3305 | 12.45 |
01:44 ET | 1005 | 12.455 |
01:45 ET | 4572 | 12.48 |
01:47 ET | 400 | 12.51 |
01:51 ET | 1400 | 12.53 |
01:54 ET | 3100 | 12.63 |
01:56 ET | 9704 | 12.5 |
01:58 ET | 504 | 12.505 |
02:00 ET | 300 | 12.505 |
02:02 ET | 100 | 12.58 |
02:03 ET | 200 | 12.505 |
02:05 ET | 8631 | 12.505 |
02:07 ET | 5536 | 12.495 |
02:09 ET | 1558 | 12.56 |
02:12 ET | 671 | 12.61 |
02:14 ET | 500 | 12.61 |
02:18 ET | 6290 | 12.635 |
02:20 ET | 3579 | 12.5 |
02:21 ET | 1909 | 12.59 |
02:23 ET | 1436 | 12.585 |
02:25 ET | 600 | 12.57 |
02:27 ET | 3910 | 12.61 |
02:32 ET | 200 | 12.6 |
02:34 ET | 300 | 12.6 |
02:36 ET | 2388 | 12.6 |
02:38 ET | 3705 | 12.74 |
02:39 ET | 971 | 12.69 |
02:41 ET | 1300 | 12.78 |
02:43 ET | 2995 | 12.75 |
02:45 ET | 1500 | 12.93 |
03:15 ET | 400 | 12.67 |
03:17 ET | 748 | 12.74 |
03:19 ET | 10242 | 12.6505 |
03:21 ET | 5109 | 12.555 |
03:24 ET | 3383 | 12.555 |
03:26 ET | 1653 | 12.555 |
03:28 ET | 107 | 12.55 |
03:30 ET | 857 | 12.555 |
03:32 ET | 20961 | 12.5 |
03:33 ET | 8991 | 12.51 |
03:35 ET | 5911 | 12.51 |
03:37 ET | 10820 | 12.5 |
03:39 ET | 1991 | 12.435 |
03:42 ET | 6148 | 12.505 |
03:44 ET | 14033 | 12.51 |
03:46 ET | 8976 | 12.4812 |
03:48 ET | 3700 | 12.49 |
03:50 ET | 3327 | 12.57 |
03:51 ET | 3778 | 12.565 |
03:53 ET | 2316 | 12.535 |
03:55 ET | 12905 | 12.65 |
03:57 ET | 14948 | 12.68 |
04:00 ET | 67077 | 12.66 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Celcuity Inc | 468.8M | -4.9x | --- |
ACELYRIN Inc | 468.1M | -1.8x | --- |
Aura Biosciences Inc | 469.8M | -5.5x | --- |
Kalvista Pharmaceuticals Inc | 465.8M | -2.7x | --- |
GH Research PLC | 472.9M | 0.0x | --- |
Monte Rosa Therapeutics Inc | 475.0M | -4.2x | --- |
Celcuity Inc. is a clinical-stage biotechnology company, which develops targeted therapies for the treatment of multiple solid tumor indications. Its lead therapeutic candidate is gedatolisib, a potent, small molecule reversible inhibitor, that selectively targets all Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic target of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2. Its initial clinical development programs for gedatolisib are focusing on the treatment of patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-), or HR+/HER2-, advanced or metastatic breast cancer and patients with metastatic castration resistant prostate cancer. Its VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast. Its CELsignia companion diagnostic platform is able to analyze live patient tumor cells to identify new groups of cancer patients.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $468.8M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 37.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.78 |
EPS | $-2.61 |
Book Value | $5.48 |
P/E Ratio | -4.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.